Therapeutic Perspectives of Inhibitors of Endocannabinoid Degradation

Publisher： Bentham Science Publishers

E-ISSN： 2212-5299|4|6|697-707

ISSN： 1568-007X

Source： Current Drug Targets-CNS & Neurological Disorders, Vol.4, Iss.6, 2005-12, pp. : 697-707

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of Endocannabinoid Degradation as Potential Therapeutic Agents: An Update

By  

Medicinal Chemistry Reviews - Online, Vol. 1, Iss. 2, 2004-04 ,pp. : 231-232

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Endocannabinoid Degradation as Potential Therapeutic Agents

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 1, Iss. 2, 2002-09 ,pp. : 103-113

Bentham Science Publishers

Access to resources Recommend Favorite

New Insights into Endocannabinoid Degradation and its Therapeutic Potential

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 3, 2006-01 ,pp. : 257-268

Bentham Science Publishers

Access to resources Recommend Favorite

Endocannabinoid Transporter Inhibitors

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 2, Iss. 2, 2002-06 ,pp. : 129-141

Bentham Science Publishers

Access to resources Recommend Favorite

The endocannabinoid system as a target for therapeutic drugs

By Piomelli D.   Giuffrida A.   Calignano A.   Rodrguez de Fonseca F.  

Trends in Pharmacological Sciences, Vol. 21, Iss. 6, 2000-06 ,pp. : 218-224

Elsevier

Access to resources Recommend Favorite